Mani S Mahadevan

Title: The Innovations of Mani S Mahadevan

Introduction

Mani S Mahadevan is a notable inventor based in Madison, WI (US). He has made significant contributions to the field of neurobiology, particularly in understanding spinal muscular atrophy. With a total of 2 patents, his work has implications for genetic research and therapeutic development.

Latest Patents

Mahadevan's latest patents include groundbreaking research on the neuronal apoptosis inhibitor protein gene sequence and mutations causative of spinal muscular atrophy. This research has mapped the gene for this autosomal recessive neurodegenerative disorder to a specific region of chromosome 5. The gene encodes a protein that shares homology with apoptosis inhibitor proteins found in viruses, leading to its designation as a neuronal apoptosis inhibitor protein (NAIP). Notably, a deletion in the NAIP domain was identified in individuals with Types I, II, and III spinal muscular atrophy, which was absent in the normal non-SMA population.

Career Highlights

Throughout his career, Mahadevan has worked with prestigious institutions, including the University of Ottawa and the Research Development Corporation of Japan. His research has contributed to a deeper understanding of genetic disorders and potential therapeutic approaches.

Collaborations

Some of his notable coworkers include Alex E MacKenzie and Robert G Korneluk, who have collaborated with him on various research projects.

Conclusion

Mani S Mahadevan's contributions to the field of neurobiology and his innovative patents highlight the importance of genetic research in understanding and potentially treating spinal muscular atrophy. His work continues to inspire advancements in medical science.